nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP1A2—type 2 diabetes mellitus	0.239	0.602	CbGaD
Methoxsalen—CYP3A4—type 2 diabetes mellitus	0.159	0.398	CbGaD
Methoxsalen—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0856	0.229	CbGbCtD
Methoxsalen—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0327	0.0874	CbGbCtD
Methoxsalen—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0288	0.077	CbGbCtD
Methoxsalen—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0257	0.0688	CbGbCtD
Methoxsalen—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0257	0.0686	CbGbCtD
Methoxsalen—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0243	0.0651	CbGbCtD
Methoxsalen—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0235	0.0628	CbGbCtD
Methoxsalen—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0205	0.0549	CbGbCtD
Methoxsalen—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0186	0.0496	CbGbCtD
Methoxsalen—CYP1A2—Losartan—type 2 diabetes mellitus	0.0166	0.0443	CbGbCtD
Methoxsalen—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0141	0.0376	CbGbCtD
Methoxsalen—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0135	0.0361	CbGbCtD
Methoxsalen—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0135	0.0361	CbGbCtD
Methoxsalen—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0127	0.0341	CbGbCtD
Methoxsalen—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0095	0.0254	CbGbCtD
Methoxsalen—CYP3A4—Losartan—type 2 diabetes mellitus	0.00869	0.0232	CbGbCtD
Methoxsalen—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000352	0.00262	CcSEcCtD
Methoxsalen—Nausea—Tolazamide—type 2 diabetes mellitus	0.000352	0.00262	CcSEcCtD
Methoxsalen—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00035	0.00261	CcSEcCtD
Methoxsalen—Rash—Nateglinide—type 2 diabetes mellitus	0.000347	0.00258	CcSEcCtD
Methoxsalen—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000346	0.00258	CcSEcCtD
Methoxsalen—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000346	0.00258	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	0.000345	0.00257	CcSEcCtD
Methoxsalen—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000343	0.00255	CcSEcCtD
Methoxsalen—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000342	0.00255	CcSEcCtD
Methoxsalen—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000341	0.00254	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.00034	0.00253	CcSEcCtD
Methoxsalen—Nausea—Acarbose—type 2 diabetes mellitus	0.000339	0.00252	CcSEcCtD
Methoxsalen—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000337	0.0025	CcSEcCtD
Methoxsalen—Erythema—Gliclazide—type 2 diabetes mellitus	0.000333	0.00248	CcSEcCtD
Methoxsalen—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000332	0.00247	CcSEcCtD
Methoxsalen—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000331	0.00247	CcSEcCtD
Methoxsalen—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000331	0.00246	CcSEcCtD
Methoxsalen—Infection—Bromocriptine—type 2 diabetes mellitus	0.000329	0.00245	CcSEcCtD
Methoxsalen—Tension—Gliclazide—type 2 diabetes mellitus	0.000327	0.00243	CcSEcCtD
Methoxsalen—Nausea—Nateglinide—type 2 diabetes mellitus	0.000326	0.00243	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000325	0.00242	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000324	0.00241	CcSEcCtD
Methoxsalen—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000324	0.00241	CcSEcCtD
Methoxsalen—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000324	0.00241	CcSEcCtD
Methoxsalen—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000323	0.00241	CcSEcCtD
Methoxsalen—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000322	0.0024	CcSEcCtD
Methoxsalen—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000322	0.0024	CcSEcCtD
Methoxsalen—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000318	0.00237	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000317	0.00236	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000316	0.00235	CcSEcCtD
Methoxsalen—Urticaria—Glipizide—type 2 diabetes mellitus	0.000313	0.00233	CcSEcCtD
Methoxsalen—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000311	0.00231	CcSEcCtD
Methoxsalen—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00031	0.0023	CcSEcCtD
Methoxsalen—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000309	0.0023	CcSEcCtD
Methoxsalen—Oedema—Glyburide—type 2 diabetes mellitus	0.000303	0.00225	CcSEcCtD
Methoxsalen—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000303	0.00225	CcSEcCtD
Methoxsalen—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000302	0.00225	CcSEcCtD
Methoxsalen—Malaise—Gliclazide—type 2 diabetes mellitus	0.000301	0.00224	CcSEcCtD
Methoxsalen—Rash—Repaglinide—type 2 diabetes mellitus	0.0003	0.00223	CcSEcCtD
Methoxsalen—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.0003	0.00223	CcSEcCtD
Methoxsalen—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.0003	0.00223	CcSEcCtD
Methoxsalen—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.0003	0.00223	CcSEcCtD
Methoxsalen—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.0003	0.00223	CcSEcCtD
Methoxsalen—Headache—Repaglinide—type 2 diabetes mellitus	0.000298	0.00222	CcSEcCtD
Methoxsalen—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000297	0.00221	CcSEcCtD
Methoxsalen—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000296	0.00221	CcSEcCtD
Methoxsalen—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000294	0.00219	CcSEcCtD
Methoxsalen—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000292	0.00217	CcSEcCtD
Methoxsalen—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000292	0.00217	CcSEcCtD
Methoxsalen—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000291	0.00216	CcSEcCtD
Methoxsalen—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000291	0.00216	CcSEcCtD
Methoxsalen—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00029	0.00216	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000286	0.00213	CcSEcCtD
Methoxsalen—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000283	0.00211	CcSEcCtD
Methoxsalen—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000283	0.00211	CcSEcCtD
Methoxsalen—Hypotension—Glyburide—type 2 diabetes mellitus	0.000283	0.00211	CcSEcCtD
Methoxsalen—Nausea—Repaglinide—type 2 diabetes mellitus	0.000283	0.0021	CcSEcCtD
Methoxsalen—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000282	0.0021	CcSEcCtD
Methoxsalen—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000281	0.00209	CcSEcCtD
Methoxsalen—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00028	0.00209	CcSEcCtD
Methoxsalen—Erythema—Metformin—type 2 diabetes mellitus	0.000279	0.00208	CcSEcCtD
Methoxsalen—Pruritus—Glipizide—type 2 diabetes mellitus	0.000278	0.00207	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000278	0.00207	CcSEcCtD
Methoxsalen—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000278	0.00207	CcSEcCtD
Methoxsalen—Vertigo—Valsartan—type 2 diabetes mellitus	0.000275	0.00205	CcSEcCtD
Methoxsalen—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000273	0.00203	CcSEcCtD
Methoxsalen—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000273	0.00203	CcSEcCtD
Methoxsalen—Malaise—Orlistat—type 2 diabetes mellitus	0.000273	0.00203	CcSEcCtD
Methoxsalen—Vertigo—Orlistat—type 2 diabetes mellitus	0.000272	0.00202	CcSEcCtD
Methoxsalen—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000271	0.00201	CcSEcCtD
Methoxsalen—Infection—Gliclazide—type 2 diabetes mellitus	0.00027	0.00201	CcSEcCtD
Methoxsalen—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00027	0.00201	CcSEcCtD
Methoxsalen—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00027	0.00201	CcSEcCtD
Methoxsalen—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000268	0.002	CcSEcCtD
Methoxsalen—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000267	0.00199	CcSEcCtD
Methoxsalen—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000267	0.00198	CcSEcCtD
Methoxsalen—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000264	0.00197	CcSEcCtD
Methoxsalen—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000263	0.00196	CcSEcCtD
Methoxsalen—Erythema—Irbesartan—type 2 diabetes mellitus	0.000263	0.00196	CcSEcCtD
Methoxsalen—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000262	0.00195	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000261	0.00195	CcSEcCtD
Methoxsalen—Dizziness—Glipizide—type 2 diabetes mellitus	0.00026	0.00194	CcSEcCtD
Methoxsalen—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00026	0.00193	CcSEcCtD
Methoxsalen—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000259	0.00193	CcSEcCtD
Methoxsalen—Tension—Irbesartan—type 2 diabetes mellitus	0.000258	0.00192	CcSEcCtD
Methoxsalen—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000258	0.00192	CcSEcCtD
Methoxsalen—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000256	0.0019	CcSEcCtD
Methoxsalen—Discomfort—Orlistat—type 2 diabetes mellitus	0.000254	0.00189	CcSEcCtD
Methoxsalen—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000254	0.00189	CcSEcCtD
Methoxsalen—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000254	0.00189	CcSEcCtD
Methoxsalen—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000253	0.00188	CcSEcCtD
Methoxsalen—Malaise—Metformin—type 2 diabetes mellitus	0.000251	0.00187	CcSEcCtD
Methoxsalen—Oedema—Valsartan—type 2 diabetes mellitus	0.00025	0.00186	CcSEcCtD
Methoxsalen—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00025	0.00186	CcSEcCtD
Methoxsalen—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000249	0.00186	CcSEcCtD
Methoxsalen—Infection—Valsartan—type 2 diabetes mellitus	0.000248	0.00185	CcSEcCtD
Methoxsalen—Rash—Glipizide—type 2 diabetes mellitus	0.000248	0.00185	CcSEcCtD
Methoxsalen—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000248	0.00185	CcSEcCtD
Methoxsalen—Erythema—Losartan—type 2 diabetes mellitus	0.000248	0.00184	CcSEcCtD
Methoxsalen—Oedema—Orlistat—type 2 diabetes mellitus	0.000247	0.00184	CcSEcCtD
Methoxsalen—Headache—Glipizide—type 2 diabetes mellitus	0.000247	0.00184	CcSEcCtD
Methoxsalen—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000246	0.00183	CcSEcCtD
Methoxsalen—Infection—Orlistat—type 2 diabetes mellitus	0.000245	0.00183	CcSEcCtD
Methoxsalen—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000244	0.00182	CcSEcCtD
Methoxsalen—Tension—Losartan—type 2 diabetes mellitus	0.000243	0.00181	CcSEcCtD
Methoxsalen—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000243	0.00181	CcSEcCtD
Methoxsalen—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000243	0.00181	CcSEcCtD
Methoxsalen—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000242	0.0018	CcSEcCtD
Methoxsalen—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000242	0.0018	CcSEcCtD
Methoxsalen—Urticaria—Glyburide—type 2 diabetes mellitus	0.000241	0.00179	CcSEcCtD
Methoxsalen—Nervousness—Losartan—type 2 diabetes mellitus	0.00024	0.00179	CcSEcCtD
Methoxsalen—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00024	0.00179	CcSEcCtD
Methoxsalen—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000239	0.00178	CcSEcCtD
Methoxsalen—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000238	0.00177	CcSEcCtD
Methoxsalen—Malaise—Irbesartan—type 2 diabetes mellitus	0.000237	0.00177	CcSEcCtD
Methoxsalen—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000236	0.00176	CcSEcCtD
Methoxsalen—Headache—Pioglitazone—type 2 diabetes mellitus	0.000236	0.00176	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000235	0.00175	CcSEcCtD
Methoxsalen—Discomfort—Metformin—type 2 diabetes mellitus	0.000235	0.00175	CcSEcCtD
Methoxsalen—Nausea—Glipizide—type 2 diabetes mellitus	0.000234	0.00174	CcSEcCtD
Methoxsalen—Hypotension—Valsartan—type 2 diabetes mellitus	0.000233	0.00174	CcSEcCtD
Methoxsalen—Rash—Glimepiride—type 2 diabetes mellitus	0.000232	0.00172	CcSEcCtD
Methoxsalen—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000231	0.00172	CcSEcCtD
Methoxsalen—Rash—Sitagliptin—type 2 diabetes mellitus	0.000231	0.00172	CcSEcCtD
Methoxsalen—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000231	0.00172	CcSEcCtD
Methoxsalen—Headache—Glimepiride—type 2 diabetes mellitus	0.00023	0.00171	CcSEcCtD
Methoxsalen—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00023	0.00171	CcSEcCtD
Methoxsalen—Headache—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00171	CcSEcCtD
Methoxsalen—Oedema—Metformin—type 2 diabetes mellitus	0.000228	0.00169	CcSEcCtD
Methoxsalen—Infection—Metformin—type 2 diabetes mellitus	0.000226	0.00168	CcSEcCtD
Methoxsalen—Insomnia—Valsartan—type 2 diabetes mellitus	0.000226	0.00168	CcSEcCtD
Methoxsalen—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000224	0.00167	CcSEcCtD
Methoxsalen—Insomnia—Orlistat—type 2 diabetes mellitus	0.000223	0.00166	CcSEcCtD
Methoxsalen—Malaise—Losartan—type 2 diabetes mellitus	0.000223	0.00166	CcSEcCtD
Methoxsalen—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000223	0.00166	CcSEcCtD
Methoxsalen—Vertigo—Losartan—type 2 diabetes mellitus	0.000222	0.00166	CcSEcCtD
Methoxsalen—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000221	0.00165	CcSEcCtD
Methoxsalen—Skin disorder—Metformin—type 2 diabetes mellitus	0.000221	0.00165	CcSEcCtD
Methoxsalen—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00022	0.00164	CcSEcCtD
Methoxsalen—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000219	0.00163	CcSEcCtD
Methoxsalen—Nausea—Glimepiride—type 2 diabetes mellitus	0.000218	0.00162	CcSEcCtD
Methoxsalen—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000218	0.00162	CcSEcCtD
Methoxsalen—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000217	0.00162	CcSEcCtD
Methoxsalen—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000217	0.00162	CcSEcCtD
Methoxsalen—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000216	0.00161	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000216	0.00161	CcSEcCtD
Methoxsalen—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000215	0.0016	CcSEcCtD
Methoxsalen—Oedema—Irbesartan—type 2 diabetes mellitus	0.000215	0.0016	CcSEcCtD
Methoxsalen—Pruritus—Glyburide—type 2 diabetes mellitus	0.000214	0.00159	CcSEcCtD
Methoxsalen—Infection—Irbesartan—type 2 diabetes mellitus	0.000213	0.00159	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000213	0.00159	CcSEcCtD
Methoxsalen—Hypotension—Metformin—type 2 diabetes mellitus	0.000213	0.00158	CcSEcCtD
Methoxsalen—Erythema—Ramipril—type 2 diabetes mellitus	0.000212	0.00158	CcSEcCtD
Methoxsalen—Rash—Bromocriptine—type 2 diabetes mellitus	0.000209	0.00155	CcSEcCtD
Methoxsalen—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000209	0.00155	CcSEcCtD
Methoxsalen—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000209	0.00155	CcSEcCtD
Methoxsalen—Tension—Ramipril—type 2 diabetes mellitus	0.000208	0.00155	CcSEcCtD
Methoxsalen—Discomfort—Losartan—type 2 diabetes mellitus	0.000208	0.00155	CcSEcCtD
Methoxsalen—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000208	0.00155	CcSEcCtD
Methoxsalen—Headache—Bromocriptine—type 2 diabetes mellitus	0.000208	0.00154	CcSEcCtD
Methoxsalen—Nervousness—Ramipril—type 2 diabetes mellitus	0.000206	0.00153	CcSEcCtD
Methoxsalen—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000204	0.00152	CcSEcCtD
Methoxsalen—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000203	0.00151	CcSEcCtD
Methoxsalen—Oedema—Losartan—type 2 diabetes mellitus	0.000202	0.0015	CcSEcCtD
Methoxsalen—Infection—Losartan—type 2 diabetes mellitus	0.000201	0.00149	CcSEcCtD
Methoxsalen—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000201	0.00149	CcSEcCtD
Methoxsalen—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0002	0.00149	CcSEcCtD
Methoxsalen—Dyspepsia—Metformin—type 2 diabetes mellitus	0.0002	0.00149	CcSEcCtD
Methoxsalen—Urticaria—Valsartan—type 2 diabetes mellitus	0.000198	0.00148	CcSEcCtD
Methoxsalen—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000197	0.00147	CcSEcCtD
Methoxsalen—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000197	0.00146	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000196	0.00146	CcSEcCtD
Methoxsalen—Urticaria—Orlistat—type 2 diabetes mellitus	0.000196	0.00146	CcSEcCtD
Methoxsalen—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000195	0.00145	CcSEcCtD
Methoxsalen—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000192	0.00143	CcSEcCtD
Methoxsalen—Malaise—Ramipril—type 2 diabetes mellitus	0.000191	0.00143	CcSEcCtD
Methoxsalen—Rash—Glyburide—type 2 diabetes mellitus	0.000191	0.00142	CcSEcCtD
Methoxsalen—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000191	0.00142	CcSEcCtD
Methoxsalen—Vertigo—Ramipril—type 2 diabetes mellitus	0.000191	0.00142	CcSEcCtD
Methoxsalen—Headache—Glyburide—type 2 diabetes mellitus	0.00019	0.00141	CcSEcCtD
Methoxsalen—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000189	0.00141	CcSEcCtD
Methoxsalen—Hypotension—Losartan—type 2 diabetes mellitus	0.000189	0.00141	CcSEcCtD
Methoxsalen—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000188	0.0014	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000185	0.00138	CcSEcCtD
Methoxsalen—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000184	0.00137	CcSEcCtD
Methoxsalen—Insomnia—Losartan—type 2 diabetes mellitus	0.000183	0.00136	CcSEcCtD
Methoxsalen—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000182	0.00135	CcSEcCtD
Methoxsalen—Urticaria—Metformin—type 2 diabetes mellitus	0.000181	0.00135	CcSEcCtD
Methoxsalen—Nausea—Glyburide—type 2 diabetes mellitus	0.00018	0.00134	CcSEcCtD
Methoxsalen—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00018	0.00134	CcSEcCtD
Methoxsalen—Discomfort—Ramipril—type 2 diabetes mellitus	0.000179	0.00133	CcSEcCtD
Methoxsalen—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000178	0.00132	CcSEcCtD
Methoxsalen—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000177	0.00132	CcSEcCtD
Methoxsalen—Pruritus—Valsartan—type 2 diabetes mellitus	0.000177	0.00132	CcSEcCtD
Methoxsalen—Pruritus—Orlistat—type 2 diabetes mellitus	0.000175	0.0013	CcSEcCtD
Methoxsalen—Oedema—Ramipril—type 2 diabetes mellitus	0.000173	0.00129	CcSEcCtD
Methoxsalen—Rash—Gliclazide—type 2 diabetes mellitus	0.000171	0.00128	CcSEcCtD
Methoxsalen—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000171	0.00128	CcSEcCtD
Methoxsalen—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000171	0.00127	CcSEcCtD
Methoxsalen—Headache—Gliclazide—type 2 diabetes mellitus	0.00017	0.00127	CcSEcCtD
Methoxsalen—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00017	0.00126	CcSEcCtD
Methoxsalen—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000168	0.00125	CcSEcCtD
Methoxsalen—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000167	0.00124	CcSEcCtD
Methoxsalen—Dizziness—Valsartan—type 2 diabetes mellitus	0.000165	0.00123	CcSEcCtD
Methoxsalen—Dizziness—Orlistat—type 2 diabetes mellitus	0.000163	0.00122	CcSEcCtD
Methoxsalen—Hypotension—Ramipril—type 2 diabetes mellitus	0.000162	0.00121	CcSEcCtD
Methoxsalen—Nausea—Gliclazide—type 2 diabetes mellitus	0.000162	0.0012	CcSEcCtD
Methoxsalen—Pruritus—Metformin—type 2 diabetes mellitus	0.000161	0.0012	CcSEcCtD
Methoxsalen—Urticaria—Losartan—type 2 diabetes mellitus	0.000161	0.00119	CcSEcCtD
Methoxsalen—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00016	0.00119	CcSEcCtD
Methoxsalen—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000158	0.00118	CcSEcCtD
Methoxsalen—Rash—Valsartan—type 2 diabetes mellitus	0.000158	0.00117	CcSEcCtD
Methoxsalen—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000157	0.00117	CcSEcCtD
Methoxsalen—Insomnia—Ramipril—type 2 diabetes mellitus	0.000157	0.00117	CcSEcCtD
Methoxsalen—Headache—Valsartan—type 2 diabetes mellitus	0.000157	0.00117	CcSEcCtD
Methoxsalen—Rash—Orlistat—type 2 diabetes mellitus	0.000156	0.00116	CcSEcCtD
Methoxsalen—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000156	0.00116	CcSEcCtD
Methoxsalen—Headache—Orlistat—type 2 diabetes mellitus	0.000155	0.00115	CcSEcCtD
Methoxsalen—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000153	0.00114	CcSEcCtD
Methoxsalen—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000152	0.00113	CcSEcCtD
Methoxsalen—Dizziness—Metformin—type 2 diabetes mellitus	0.00015	0.00112	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.00015	0.00111	CcSEcCtD
Methoxsalen—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000149	0.00111	CcSEcCtD
Methoxsalen—Nausea—Valsartan—type 2 diabetes mellitus	0.000148	0.0011	CcSEcCtD
Methoxsalen—Nausea—Orlistat—type 2 diabetes mellitus	0.000147	0.00109	CcSEcCtD
Methoxsalen—Rash—Metformin—type 2 diabetes mellitus	0.000143	0.00107	CcSEcCtD
Methoxsalen—Dermatitis—Metformin—type 2 diabetes mellitus	0.000143	0.00107	CcSEcCtD
Methoxsalen—Pruritus—Losartan—type 2 diabetes mellitus	0.000143	0.00106	CcSEcCtD
Methoxsalen—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000143	0.00106	CcSEcCtD
Methoxsalen—Headache—Metformin—type 2 diabetes mellitus	0.000143	0.00106	CcSEcCtD
Methoxsalen—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000142	0.00106	CcSEcCtD
Methoxsalen—Urticaria—Ramipril—type 2 diabetes mellitus	0.000138	0.00102	CcSEcCtD
Methoxsalen—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000137	0.00102	CcSEcCtD
Methoxsalen—Rash—Irbesartan—type 2 diabetes mellitus	0.000135	0.00101	CcSEcCtD
Methoxsalen—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000135	0.00101	CcSEcCtD
Methoxsalen—Nausea—Metformin—type 2 diabetes mellitus	0.000135	0.00101	CcSEcCtD
Methoxsalen—Headache—Irbesartan—type 2 diabetes mellitus	0.000135	0.001	CcSEcCtD
Methoxsalen—Dizziness—Losartan—type 2 diabetes mellitus	0.000134	0.000995	CcSEcCtD
Methoxsalen—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000128	0.00095	CcSEcCtD
Methoxsalen—Nausea—Irbesartan—type 2 diabetes mellitus	0.000128	0.000949	CcSEcCtD
Methoxsalen—Rash—Losartan—type 2 diabetes mellitus	0.000127	0.000948	CcSEcCtD
Methoxsalen—Dermatitis—Losartan—type 2 diabetes mellitus	0.000127	0.000948	CcSEcCtD
Methoxsalen—Headache—Losartan—type 2 diabetes mellitus	0.000127	0.000942	CcSEcCtD
Methoxsalen—Pruritus—Ramipril—type 2 diabetes mellitus	0.000123	0.000912	CcSEcCtD
Methoxsalen—Nausea—Losartan—type 2 diabetes mellitus	0.00012	0.000893	CcSEcCtD
Methoxsalen—Dizziness—Ramipril—type 2 diabetes mellitus	0.000115	0.000853	CcSEcCtD
Methoxsalen—Rash—Ramipril—type 2 diabetes mellitus	0.000109	0.000813	CcSEcCtD
Methoxsalen—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000109	0.000812	CcSEcCtD
Methoxsalen—Headache—Ramipril—type 2 diabetes mellitus	0.000109	0.000808	CcSEcCtD
Methoxsalen—Nausea—Ramipril—type 2 diabetes mellitus	0.000103	0.000766	CcSEcCtD
Methoxsalen—CYP2A6—Metabolism—SNAP25—type 2 diabetes mellitus	1.33e-05	0.000142	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—SREBF1—type 2 diabetes mellitus	1.33e-05	0.000142	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.32e-05	0.00014	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.32e-05	0.00014	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CTGF—type 2 diabetes mellitus	1.3e-05	0.000139	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.29e-05	0.000138	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—HMGCR—type 2 diabetes mellitus	1.29e-05	0.000138	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.27e-05	0.000135	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.26e-05	0.000135	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.26e-05	0.000134	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.26e-05	0.000134	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.25e-05	0.000134	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.25e-05	0.000133	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.25e-05	0.000133	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GLP1R—type 2 diabetes mellitus	1.24e-05	0.000132	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.22e-05	0.000131	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.21e-05	0.00013	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.2e-05	0.000128	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.2e-05	0.000128	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.19e-05	0.000127	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.17e-05	0.000125	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.17e-05	0.000125	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.17e-05	0.000125	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.17e-05	0.000125	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.16e-05	0.000123	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GCG—type 2 diabetes mellitus	1.15e-05	0.000123	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.15e-05	0.000123	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—MTR—type 2 diabetes mellitus	1.13e-05	0.000121	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CPT1A—type 2 diabetes mellitus	1.13e-05	0.000121	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.12e-05	0.00012	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.12e-05	0.00012	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NAMPT—type 2 diabetes mellitus	1.11e-05	0.000118	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.1e-05	0.000118	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—LIPC—type 2 diabetes mellitus	1.1e-05	0.000118	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—HBA1—type 2 diabetes mellitus	1.1e-05	0.000118	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GCK—type 2 diabetes mellitus	1.1e-05	0.000118	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.1e-05	0.000117	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.1e-05	0.000117	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.1e-05	0.000117	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.08e-05	0.000115	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.08e-05	0.000115	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.08e-05	0.000115	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CETP—type 2 diabetes mellitus	1.06e-05	0.000114	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.06e-05	0.000113	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.06e-05	0.000113	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.06e-05	0.000113	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.06e-05	0.000113	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.06e-05	0.000113	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.06e-05	0.000113	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.06e-05	0.000113	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.04e-05	0.000111	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.04e-05	0.000111	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.04e-05	0.000111	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.03e-05	0.00011	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.01e-05	0.000108	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GNB3—type 2 diabetes mellitus	9.92e-06	0.000106	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.92e-06	0.000106	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.92e-06	0.000106	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SREBF1—type 2 diabetes mellitus	9.89e-06	0.000106	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PSMD6—type 2 diabetes mellitus	9.89e-06	0.000106	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SNAP25—type 2 diabetes mellitus	9.89e-06	0.000106	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—HMOX1—type 2 diabetes mellitus	9.88e-06	0.000105	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	9.79e-06	0.000104	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CAT—type 2 diabetes mellitus	9.75e-06	0.000104	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—AKT1—type 2 diabetes mellitus	9.72e-06	0.000104	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CTGF—type 2 diabetes mellitus	9.71e-06	0.000104	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	9.7e-06	0.000104	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	9.7e-06	0.000104	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.64e-06	0.000103	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—HMGCR—type 2 diabetes mellitus	9.62e-06	0.000103	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.49e-06	0.000101	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—APOB—type 2 diabetes mellitus	9.46e-06	0.000101	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.45e-06	0.000101	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.42e-06	0.000101	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.4e-06	0.0001	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	9.2e-06	9.82e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	9.17e-06	9.79e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.16e-06	9.77e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	9.05e-06	9.66e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	9.04e-06	9.64e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.02e-06	9.62e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.02e-06	9.62e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.02e-06	9.62e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.95e-06	9.55e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.95e-06	9.55e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	8.85e-06	9.45e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	8.85e-06	9.45e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	8.85e-06	9.45e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	8.85e-06	9.45e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	8.85e-06	9.44e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	8.81e-06	9.41e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.73e-06	9.31e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.68e-06	9.27e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.64e-06	9.23e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.64e-06	9.23e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	8.58e-06	9.16e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.58e-06	9.16e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	8.58e-06	9.16e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.51e-06	9.09e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	8.49e-06	9.06e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	8.48e-06	9.05e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.32e-06	8.88e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.32e-06	8.88e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.25e-06	8.8e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.17e-06	8.72e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	8.13e-06	8.68e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.08e-06	8.62e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.04e-06	8.58e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.04e-06	8.58e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.04e-06	8.58e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.99e-06	8.52e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	7.98e-06	8.52e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	7.89e-06	8.42e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	7.73e-06	8.25e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	7.6e-06	8.11e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	7.57e-06	8.08e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.56e-06	8.06e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	7.49e-06	7.99e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	7.39e-06	7.89e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.39e-06	7.89e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.37e-06	7.86e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	7.36e-06	7.86e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	7.26e-06	7.75e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	7.22e-06	7.7e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	7.22e-06	7.7e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	7.08e-06	7.55e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.08e-06	7.55e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	7.05e-06	7.52e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.04e-06	7.51e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	7.03e-06	7.51e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	7.03e-06	7.51e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	7.03e-06	7.51e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	6.99e-06	7.46e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.87e-06	7.33e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	6.86e-06	7.32e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.83e-06	7.29e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.83e-06	7.29e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.83e-06	7.29e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.83e-06	7.29e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	6.79e-06	7.24e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	6.73e-06	7.19e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	6.6e-06	7.04e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	6.59e-06	7.03e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	6.57e-06	7.01e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.55e-06	6.99e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	6.47e-06	6.91e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	6.4e-06	6.83e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.33e-06	6.75e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.32e-06	6.74e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.31e-06	6.73e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.31e-06	6.73e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.31e-06	6.73e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	6.19e-06	6.61e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	6.14e-06	6.55e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.09e-06	6.5e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	6.06e-06	6.47e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.05e-06	6.46e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	6.01e-06	6.41e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	5.95e-06	6.35e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	5.93e-06	6.33e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.77e-06	6.16e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	5.76e-06	6.15e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.71e-06	6.09e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.69e-06	6.07e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	5.67e-06	6.06e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.67e-06	6.06e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	5.66e-06	6.04e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	5.64e-06	6.02e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	5.58e-06	5.95e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.57e-06	5.95e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.57e-06	5.95e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.56e-06	5.94e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.54e-06	5.91e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.47e-06	5.84e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	5.47e-06	5.84e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.46e-06	5.83e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.43e-06	5.79e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.43e-06	5.79e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.43e-06	5.79e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.39e-06	5.76e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.3e-06	5.66e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.24e-06	5.59e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	5.19e-06	5.54e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	4.91e-06	5.25e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.87e-06	5.2e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.87e-06	5.2e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.87e-06	5.2e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	4.82e-06	5.15e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.78e-06	5.1e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.74e-06	5.06e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.71e-06	5.03e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.71e-06	5.03e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.69e-06	5.01e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.64e-06	4.95e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.63e-06	4.94e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.5e-06	4.8e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.45e-06	4.75e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	4.42e-06	4.72e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.4e-06	4.7e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.4e-06	4.7e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.37e-06	4.67e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.29e-06	4.58e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	4.23e-06	4.51e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.23e-06	4.51e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.22e-06	4.51e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.22e-06	4.51e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.2e-06	4.49e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.19e-06	4.47e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.08e-06	4.35e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.03e-06	4.3e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.87e-06	4.13e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.86e-06	4.12e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.79e-06	4.05e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.67e-06	3.92e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.64e-06	3.88e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.64e-06	3.88e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.62e-06	3.87e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.61e-06	3.85e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.6e-06	3.84e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.57e-06	3.81e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.56e-06	3.8e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.47e-06	3.7e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.37e-06	3.6e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.31e-06	3.54e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.24e-06	3.46e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.23e-06	3.45e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.15e-06	3.36e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.13e-06	3.34e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.11e-06	3.32e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.07e-06	3.28e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.98e-06	3.18e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.93e-06	3.12e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.83e-06	3.02e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.82e-06	3.01e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.79e-06	2.97e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.78e-06	2.96e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.74e-06	2.93e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.7e-06	2.88e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.7e-06	2.88e-05	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	2.61e-06	2.78e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.47e-06	2.63e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.42e-06	2.58e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.37e-06	2.53e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.17e-06	2.32e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.08e-06	2.22e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.08e-06	2.22e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.94e-06	2.07e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.9e-06	2.03e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	1.32e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.56e-07	1.02e-05	CbGpPWpGaD
